Inpatient Rehab for Kensington Philadelphia Residents
Kensington and the surrounding River Wards carry the heaviest overdose burden in Philadelphia — 76% of River Ward residents told Pew in 2025 that the opioid crisis has a negative impact on their neighborhood quality of life, up from 64% in 2019.
The Kensington Drug Landscape
Kensington Avenue has been Philadelphia's open-air drug market for over a decade. The supply is dominated by fentanyl adulterated with xylazine (38% of 2023 overdose deaths involved xylazine) and, increasingly, medetomidine (87% of drug samples tested by January 2025, per DEA Operation Engage). Pure heroin has essentially disappeared from the supply. Most callers from Kensington present with combined fentanyl/xylazine use, often with associated skin wounds, and frequently with homelessness or unstable housing.
Xylazine-Aware Detox
Standard opioid detox protocols — buprenorphine or methadone with clonidine — manage the fentanyl component but not the xylazine or medetomidine component. Kensington callers who detox in programs without xylazine/medetomidine protocols often report days of continuing vomiting, tremors, sweating, and racing heart after opioid symptoms resolve. The licensed programs in our referral network that specifically manage Philadelphia-area callers use gabapentin, clonidine, tizanidine, and other non-opioid adjuncts for this second phase.
Talk to a placement advisor now.
Call (215) 302-0133 for free insurance verification. No obligation. Advisors answer around the clock.
Wound Care and Inpatient Admission
Xylazine causes characteristic chronic, necrotic ulcers that can occur at injection sites or elsewhere on the body (including in people who only snort, not inject). Severe wounds sometimes require surgical debridement or even amputation — Philadelphia hospitals saw more than 200 addiction-related ICU admissions in 2024. Several programs in our referral network admit callers with active wounds, manage them during detox and rehab, and coordinate outpatient wound care at discharge. Mention wounds to the placement advisor on the first call.
Local Harm Reduction Context
Prevention Point Philadelphia (2913 Kensington Avenue) is the primary harm reduction resource in the neighborhood, offering free naloxone, fentanyl and medetomidine test strips, wound care, HIV/HCV testing, and linkage to treatment. The city's Naloxone in Black initiative, launched August 2025, places free naloxone boxes outside 61 fire stations citywide. None of these resources are affiliated with us — they are independent harm-reduction services Kensington residents can access directly before or after engaging with placement.
Insurance and Placement
Many Kensington callers are uninsured or on Medicaid, which our placement advisors do not handle — those callers should contact Philadelphia Community Behavioral Health at (888) 545-2600 or BHSI at (215) 546-1200 for city-funded treatment access. For Kensington callers with commercial PPO or HMO coverage (often from family members' employer plans), Act 106 applies and placement advisors can coordinate licensed inpatient admission with xylazine-capable programs.
Directions to the Placement Office
By car from Kensington
From Kensington Avenue: head south on Kensington Ave, turn right onto Girard Ave, left onto N 2nd St, continue as it becomes Christopher Columbus Blvd, then right onto Market Street and follow Market west to 1500. Approximately 10-15 minutes depending on traffic. Alternative: take I-95 south to exit 22 and cut back west on I-676 — faster during Girard Avenue congestion.
By SEPTA transit from Kensington
SEPTA Market-Frankford Line (Blue Line): board at Somerset, Allegheny, or Tioga Stations going southbound toward 69th Street. Exit at 15th Street Station or City Hall. One-block walk west to 1500 Market. Total travel time 15-25 minutes.
Frequently Asked Questions
Do the programs you refer to accept callers with xylazine wounds?
I don't have insurance. Can you help?
Is naloxone available free in Kensington?
Talk to a placement advisor now.
Call (215) 302-0133 for free insurance verification. No obligation. Advisors answer around the clock.